Global Regulatory Agencies

Food and Drug Administration leads global NAMs adoption with Modernization Act 2.0/3.0 removing animal testing mandates.

Health Canada harmonizes with FDA through MRA agreements, accepting NAMs data case-by-case in drug submissions.

European Medicines Agency provides formal qualification opinions through SAWP, enabling NAMs across 27 member states.

Medicines and Healthcare products Regulatory Agency pioneering post-Brexit innovation with ILAP and accelerated NAMs pathways.

Swiss Agency for Therapeutic Products collaborates with EMA and FDA on NAMs acceptance through mutual recognition.

Pharmaceuticals and Medical Devices Agency advancing MPS through AMED program and ICH collaboration.

National Medical Products Administration expanding NAMs acceptance with $500M+ investment in organ-on-chip capabilities.

Ministry of Food and Drug Safety implementing NAMs pilot programs with strong domestic organ-on-chip industry.

Therapeutic Goods Administration accepting NAMs through mutual recognition with FDA, EMA, and Health Canada.

Health Sciences Authority accepting NAMs data through ACSS consortium and bilateral agreements with major agencies.

Saudi Food and Drug Authority implementing Vision 2030 biotech strategy with NAMs pilot programs and KFSH collaboration.

Ministry of Health Israel enabling strong biotech ecosystem with FDA-harmonized pathways for NAMs acceptance.

Agencia Nacional de Vigilancia Sanitaria developing NAMs framework aligned with ICH guidelines and FDA cooperation.